Industry Focus

An EpiPen pricing debacle, an unexpected FDA rejection, and a sticker-shock inspiring M&A deal led to wild moves in Mylan N.V., Portola Pharmaceuticals, and Medivation this week.

 

Direct download: 08242016_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EST